DaisukeKotani· @DaisukeKotani · X·· 4 天前评分60
正文 · 原文
#ESMO26 | 787RO BRICKET: Ph2 re-treatment with EC in BRAF V600E mCRC @myESMO @OncoAlert https://t.co/yZbBiPWhPE
热度 11 · 8 赞 · 0 回复 · 3 转发
会议摘要
NCT06578559NCT06578559按 - **标题 / Title：** Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC 对上
- **标题 / Title：** Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC读摘要原文 →来源：DaisukeKotani · x.com